NDC 51672-1365-04 - Fluocinolone Acetonide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1365
- Requested NDC
- 51672-1365-04
- Package NDCs from labels
- 51672-1365-2, 51672-1365-4, 51672-1365-04
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fluocinolone Acetonide Topical Solution USP, 0.01% | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1365-2 | Fluocinolone Acetonide | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 51672-1365-2 | Fluocinolone Acetonide | 20 mL in 1 BOTTLE | SOLUTION | 20 | 3 | |
| 51672-1365-4 | Fluocinolone Acetonide | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 51672-1365-4 | Fluocinolone Acetonide | 60 mL in 1 BOTTLE | SOLUTION | 60 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1365 | FLUOCINOLONE ACETONIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | Current NDC, Legacy NDC, 4 package rows | 20170421_02352ed1-3568-441f-add8-45201351a11c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1365-4 | ML - Milliliter | 51672-1365 | bf5c5a2c-bf1b-450d-94e6-4e47bbabbbe9 | 1 | 2015-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| fluocinolone acetonide | ACTIVE INGREDIENT | 0CD5FD6S2M | FLUOCINOLONE ACETONIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| fluocinolone acetonide | ACTIVE MOIETY | 0CD5FD6S2M | FLUOCINOLONE ACETONIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| citric acid monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | FLUOCINOLONE ACETONIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | FLUOCINOLONE ACETONIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fluocinolone acetonide | FLUOCINOLONE ACETONIDE | Bryant Ranch Prepack | 4790bdfa-c964-4c3e-9d01-c2fb23a0172e | 2026-05-26 | Warnings, Adverse reactions | 0CD5FD6S2M |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | 2968PHW8QP |
| Systane Pro PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a12baf3d-f22b-4c9f-a4c8-4e0d09f6d6f1 | 2026-05-12 | Warnings | 6DC9Q167V3 |
| Fluocinolone acetonide | FLUOCINOLONE ACETONIDE | A-S Medication Solutions | 09284ede-6be9-4192-b178-567b3c6265bb | 2026-05-08 | Warnings, Adverse reactions | 0CD5FD6S2M |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, PROPYLENE GLYCOL | CVS Pharmacy | 28297fee-8185-4869-8f39-5bfbf8bf8bfd | 2026-04-13 | Warnings | 6DC9Q167V3 |
| Retaine Ultra PF | POLYETHYLENE GLYCOL | OCuSOFT LLC | a5aaaf06-772d-44d3-8601-f978ddc48ad7 | 2026-04-13 | Warnings | 6DC9Q167V3 |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC | 58c24504-47de-487a-ab8d-18add155ea95 | 2026-04-07 | Adverse reactions | 2968PHW8QP |
| Fluocinolone Acetonide Topical Solution USP, 0.01% | FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01% | Encube Ethicals, Inc. | 3fb00d90-6a5b-4e95-ab6b-f5b102ff0f36 | 2026-03-18 | Adverse reactions | 1191310 0CD5FD6S2M |
| Neo-Synalar | NEOMYCIN SULFATE AND FLUOCINOLONE ACETONIDE | Eurofarma, Inc. | 1141956e-8a4c-4f80-95d1-f15bdb57fdf6 | 2026-03-18 | Warnings, Adverse reactions | 0CD5FD6S2M |
| Leader Ultra Lubricating Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Cardinal Health | d7f011a2-05ba-47c3-9519-d31602e105c7 | 2026-03-12 | Warnings | 6DC9Q167V3 |
| Leader Restorative Formula Lubricant Eye Drops | PROPYLENE GLYCOL | Cardinal Health | 87fef7e4-e5a8-4aad-94d2-f80f34826d97 | 2026-03-12 | Warnings | 6DC9Q167V3 |
| Fluocinolone Acetonide Oil | FLUOCINOLONE ACETONIDE | Rising Pharma Holdings, Inc. | 79591576-1eab-48c5-b0a6-e205b3cc097e | 2026-03-09 | Warnings, Adverse reactions | 0CD5FD6S2M |
| Fluocinolone Acetonide Oil | FLUOCINOLONE ACETONIDE | Rising Pharma Holdings, Inc. | f45b0ef2-1702-4d21-8ac8-774769304595 | 2026-03-09 | Warnings, Adverse reactions | 0CD5FD6S2M |
| Tricitrates | TRICITRATES | Chartwell Governmental & Specialty RX, LLC. | c4ff0407-3930-4c48-afd4-d2cb3e1b18f4 | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC. | fd57a176-7faf-4053-b348-6ba5f192f05a | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| fluocinolone acetonide | FLUOCINOLONE ACETONIDE | ANI Pharmaceuticals, Inc. | 50e7006d-a51b-49aa-8e1c-330340e7bf82 | 2026-02-23 | Adverse reactions | 0CD5FD6S2M |
| Fluocinolone Acetonide | FLUOCINOLONE ACETONIDE | ANI Pharmaceuticals, Inc. | 622c9804-0be0-4dec-a6ba-5cf4b5578a84 | 2026-02-23 | Adverse reactions | 0CD5FD6S2M |
| YUTIQ | FLUOCINOLONE ACETONIDE | ANI Pharmaceuticals, Inc. | f270cad8-ed82-4969-b785-831a1910bfa6 | 2026-02-19 | Warnings, Adverse reactions | 0CD5FD6S2M |
| Fluocinolone Acetonide Topical Solution USP, 0.01% | FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01% | Bryant Ranch Prepack | 3fa4d5db-b17f-44dc-aa6a-50934d42c68d | 2026-02-18 | Adverse reactions | 1191310 0CD5FD6S2M |
| Droptics Performance Eye Drops | NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL | Droptics LLC | 20fd6822-a7fd-4593-92bb-0a07260893e2 | 2026-02-09 | Warnings | 6DC9Q167V3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.